|
|
|
|
|
|
|
|
|
|
|
|
|
13.01.26 - 23:12
|
Tempus CEO on AI In Healthcare Space (Bloomberg)
|
|
|
Tempus AI CEO Eric Lefkofsky joins Bloomberg's Katie Greifeld at the annual JP Morgan healthcare conference in San Francisco to talk about how they incorporate AI into every day consumer's lives. He shared that they plan to bring the benefit of data training to AI in the healthcare space. (Source: Bloomberg)...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11.01.26 - 23:03
|
Tempus Announces Preliminary Fourth Quarter and Full Year 2025 Results (Business Wire)
|
|
|
CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced select, preliminary, unaudited results for the fourth quarter and full year ended December 31, 2025.
Full Year 2025 Select, Preliminary, Unaudited Financial Results
Revenue of ~$1.27 billion, representing ~83% growth year-over-year, including ~30% organic growth (excluding Ambry)
Diagnostics revenue of ~$955 million, representing ~111% growth year-over-year, driven by Oncology volume growth of ~26% and Hereditary volume growth of ~29%
Data and applications revenue of ~$316 million, representing ~31% growth year-over-year, driven by ~38% growth in Insights (Data Licensing)
Fourth Quarter 2025 Select, Preliminary, Unaudited Financial Results
Revenue of approximately ~$367 million, an increase of approximately 83% year-over-year
Diagnostics revenue of ~$266 million, representing ~121% growth year-over-year, driven by Oncology volume growth of ~29% and Heredit...
|
|
|
|